Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell signaling network profiling during redox stress reveals dynamic redox regulation in immune cells.
Wang YC, Wu PH, Ting WC, Wang YF, Yang MH, Su TH, Su JY, Sun HI, Huang WM, Tsai PL, Wernig G, Ho PC, Wang L, Wu CT, Chang YL, Chen TC, Meng TC, Chang YM, Lai SL, Li CW, Ko TM, Yang KC, Chang YJ, Chern Y, Kuo MC, Huang YT, Tzeng YS, Tang JL, Chen SY. Wang YC, et al. Among authors: yang mh. Nat Commun. 2025 Jul 1;16(1):5600. doi: 10.1038/s41467-025-60727-z. Nat Commun. 2025. PMID: 40593569
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 study.
Tang LQ, Liu SL, Yang MH, Wang HC, Zhou YJ, Yang KY, Li Q, Hui M, Chen XZ, Leu YS, Chen LT, Liu LT, Guo SS, Chen QY, Wang S, Zhu HQ, Shen HG, Wang Y, Guo Y, Mai HQ. Tang LQ, et al. Among authors: yang mh. Clin Cancer Res. 2025 Jun 13. doi: 10.1158/1078-0432.CCR-25-0085. Online ahead of print. Clin Cancer Res. 2025. PMID: 40512241
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Fayette J, Licitra L, Harrington K, Haddad R, Siu LL, Liu YC, Tahara M, Machiels JP, Rischin D, Seiwert TY, Ferris RL, Keilholz U, Psyrri A, Keam B, Bossi P, Metcalf R, Hsieh CY, Clement PMJ, Isaev P, Mudunov A, Dinis J, Hoeben A, Kasper S, Klinghammer K, Hwang M, Blando J, Serrano O, Ruscica D, Cohen RB; INTERLINK-1 investigators. Fayette J, et al. Clin Cancer Res. 2025 Jul 1;31(13):2617-2627. doi: 10.1158/1078-0432.CCR-25-0073. Clin Cancer Res. 2025. PMID: 40300079 Free PMC article. Clinical Trial.
1,435 results